Direct Oral Anticoagulants for the Management of Thromboembolic Disorders
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct Oral Anticoagulants for the Management of Thromboembolic Disorders
Authors
Keywords
-
Journal
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
Volume 22, Issue 7, Pages 605-616
Publisher
SAGE Publications
Online
2015-08-28
DOI
10.1177/1076029615601492
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
- (2015) J. Beyer-Westendorf et al. EUROPACE
- Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation
- (2015) Franziska Ebertz et al. THROMBOSIS AND HAEMOSTASIS
- Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial
- (2015) Martin H. Prins et al. THROMBOSIS RESEARCH
- Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
- (2014) François Laliberté et al. CURRENT MEDICAL RESEARCH AND OPINION
- Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
- (2014) Winnie W. Nelson et al. CURRENT MEDICAL RESEARCH AND OPINION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Additional Events in the RE-LY Trial
- (2014) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial
- (2014) Jonathan P. Piccini et al. Journal of the American Heart Association
- Current State of Anticoagulants to Treat Deep Venous Thrombosis
- (2014) Timothy Vo et al. Current Cardiology Reports
- Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
- (2013) Lars Wallentin et al. CIRCULATION
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
- (2013) Sam Schulman et al. CIRCULATION
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
- (2013) Irene Savelieva et al. CLINICAL CARDIOLOGY
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary†
- (2013) Hein Heidbuchel et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adherence to anticoagulant treatment with dabigatran in a real-world setting
- (2013) S. Schulman et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
- (2013) Reinhold Kreutz JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
- (2013) Ajay K. Kakkar et al. PLoS One
- Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis
- (2013) Luke Bamber et al. THROMBOSIS AND HAEMOSTASIS
- Epidemiology and mortality of venous thromboembolism across patient populations: A systematic literature review
- (2013) X. Liu et al. VALUE IN HEALTH
- The new oral anticoagulants in atrial fibrillation: Once daily or twice daily?
- (2013) Giulia Renda et al. VASCULAR PHARMACOLOGY
- Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients
- (2012) François Laliberté et al. ADVANCES IN THERAPY
- A new taxonomy for describing and defining adherence to medications
- (2012) Bernard Vrijens et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ARISTOTLE RE-LYs on the ROCKET. What’s new in stroke prevention in patients with atrial fibrillation?
- (2012) Michał Tendera et al. Cardiology Journal
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007
- (2012) Jonathan P. Piccini et al.
- Long-term benefits of preventing venous thromboembolic events
- (2012) Alexander T. Cohen CURRENT MEDICAL RESEARCH AND OPINION
- Effect of dosing frequency on chronic cardiovascular disease medication adherence
- (2012) Craig I. Coleman et al. CURRENT MEDICAL RESEARCH AND OPINION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding
- (2012) Irene M. Lang et al. EUROPEAN RESPIRATORY JOURNAL
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing adherence in hypertension: a comparison of outcomes and costs using single tablet regimens vs individual component regimens
- (2012) J. D. Belsey JOURNAL OF MEDICAL ECONOMICS
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Hypertension and atrial fibrillation
- (2011) Athanasios J. Manolis et al. JOURNAL OF HYPERTENSION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections
- (2010) S. B. Deitelzweig et al. AMERICAN JOURNAL OF HEMATOLOGY
- Current Treatment of Venous Thromboembolism
- (2010) Nigel S. Key et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Anticoagulants
- (2010) John W. Eikelboom et al. CIRCULATION
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Newly Identified Events in the RE-LY Trial
- (2010) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Increasing Prevalence of Atrial Fibrillation and Flutter in the United States
- (2009) Gerald V. Naccarelli et al. AMERICAN JOURNAL OF CARDIOLOGY
- Contemporary Issues in the Prevention and Management of Postthrombotic Syndrome
- (2009) Sara R Vazquez et al. ANNALS OF PHARMACOTHERAPY
- Venous Thromboembolism
- (2009) Tienan Zhu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The new oral anticoagulants
- (2009) D. Garcia et al. BLOOD
- Medication Adherence
- (2009) P. Michael Ho et al. CIRCULATION
- Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis
- (2009) Jean‐Jacques Parienti et al. CLINICAL INFECTIOUS DISEASES
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
- (2008) H. R. Buller et al. BLOOD
- Apixaban, an oral, direct and highly selective factor Xa inhibitor:in vitro, antithrombotic and antihemostatic studies
- (2008) P. C. WONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and safety of the oral direct factorXa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study
- (2008) et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Medication Compliance and Persistence: Terminology and Definitions
- (2007) Joyce A. Cramer et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search